About Us
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
Follow Us
Secure Payments
|
|
|
| Previous Close | $4.37 | Open | $4.40 |
| Volume | 114.5K | Market Cap | 55.43M |
| Yield | Last Dividend |
| Anixa's Stock Craters As FDA Slaps Clini... | 04/19/21 |
| Anixa Biosciences Inc (NASDAQ: ANIX ) shares drop after the FDA has requested additional information on its Chimeric Antigen Receptor-T cell therapy (... | |
| Anixa Biosciences Increases Previously A... | 03/22/21 |
| SAN JOSE, Calif. , March 22, 2021 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX ) ("Anixa" or the "Company"), a biotechnology company focused ... | |
| Anixa Biosciences Announces $10 Million ... | 03/22/21 |
| SAN JOSE, Calif., March 22, 2021 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX) ("Anixa" or the "Company"), a biotechnology company focused on... | |
| Anixa Biosciences and Moffitt Cancer Cen... | 03/22/21 |
| SAN JOSE, Calif., March 22, 2021 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on the treatment and preventi... | |
| The Daily Biotech Pulse: Sarepta Gene Th... | 03/19/21 |
| Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs March 18) An... | |
| The Daily Biotech Pulse: Translate Bio's... | 03/18/21 |
| Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs March 17) An... | |
| Anixa Biosciences Did they just beat EPS... | 03/15/21 |
| Anixa Biosciences announce their quarterly, annual earnings. See the latest EPS estimates. Listen to the conference call and remind yourself by??? | |
| Anixa Biosciences Announces Issuance and... | 03/12/21 |
| SAN JOSE, Calif., March 12, 2021 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on the treatment and preventi... | |
| Anixa Biosciences to Participate in M Ve... | 03/08/21 |
| SAN JOSE, Calif., March 8, 2021 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on the treatment and preventio... | |
| Anixa Biosciences Announces European Pat... | 03/04/21 |
| /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer and infectious disea... | |
| Anixa Biosciences to Present at the H.C.... | 02/25/21 |
| SAN JOSE, Calif., Feb. 25, 2021 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on the treatment and preventio... | |
| Interview: Dr Amit Kumar, CEO of Anixa B... | 02/16/21 |
| Dr Amit Kumar is currently Chairman, President, and CEO of Anixa Biosciences, a biotechnology company developing several programs addressing cancer an... | |
| Anixa Biosciences Begins Animal Testing ... | 02/16/21 |
| SAN JOSE, Calif., Feb. 16, 2021 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on the treatment and preventio... | |
| Anixa Biosciences to Present at the B. R... | 01/13/21 |
| SAN JOSE, Calif., Jan. 13, 2021 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on the treatment and preventio... | |
| Worldwide Industry for CAR-T Cell Therap... | 01/07/21 |
| DUBLIN , Jan. 7, 2021 /PRNewswire/ -- The "Global CAR-T Cell Therapy Market - Market Size, Forecasts, Trials and Trends, 2021" report has been added t... | |
| Anixa Biosciences to Present at the H.C.... | 01/05/21 |
| SAN JOSE, Calif., Jan. 5, 2021 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention... | |
| Anixa Biosciences Covid-19 Therapy Demon... | 12/14/20 |
| SAN JOSE, Calif., Dec. 14, 2020 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on the treatment and preventio... | |
| Analyzing The Price Action In Anixa Bios... | 12/10/20 |
| Anixa Biosciences???s Stock Price And Volume Action Anixa Biosciences???s (NASDAQ: ANIX) stock has been rising Thursday, up 77.85% to a price of ??? | |
| Anixa Biosciences to Host Conference Cal... | 10/27/20 |
| SAN JOSE, Calif., Oct. 27, 2020 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on the treatment and preventio... | |
| 51 Biggest Movers From Yesterday | 10/02/20 |
| Gainers Solid Biosciences Inc. (NASDAQ: SLDB ) shares climbed 70.4% to close at $3.46 on Thursday after the company announced the FDA has lifted the c... | |
| Anixa Biosciences to Present at the 2020... | 09/08/20 |
| SAN JOSE, Calif., Sept. 8, 2020 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on the treatment and preventio... | |
| Anixa nabs European patent covering CAR-... | 07/10/20 |
| Thinly traded nano cap Anixa Biosciences (NASDAQ:ANIX) jumps 11% premarket on increased volume in reaction to its announcement that it has received an... | |
| Anixa Biosciences' CAR-T Cancer Therapy ... | 07/10/20 |
| SAN JOSE, Calif. , July 10, 2020 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX ), a biotechnology company focused on the treatment and prevent... | |
| Anixa and OntoChem complete initial scre... | 07/06/20 |
| Anixa Biosciences (ANIX -6.3%) along with its partner, OntoChem has completed the initial in silico screening process of their drug discovery program ... | |
| Anixa Announces Strategic Program Realig... | 07/02/20 |
| SAN JOSE, Calif., July 2, 2020 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention... | |
| ViewRay and NantKwest among healthcare g... | 06/30/20 |
| Gainers: Calliditas Therapeutics (NASDAQ:CALT) +20%. ViewRay (NASDAQ:VRAY) +19%. Anixa Biosciences (NASDAQ:ANIX) +19%. OptiNose (NASDAQ:OPTN) +18%. Na... | |
| Buy rating | 04/12/21 |
| HC Wainwright & Co. initiates coverage with Buy rating and announces Price Target of $11.00 | |
| Date | 04/12/2019 (AMC) | Est. (EPS/Rev.) | $1.37 |
| Actual (EPS/Rev.) | $2.5B | EPS (TTM) | $??? |
| Total Revenue | $1.3B | Total Liabilities | $2.1B |
| Cost of Revenue | $2.5B | Total cash flow | $3.2 |
| Total Assets | $29.98B |
| % Insider | 12.52% | % Institutional | 76.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Service Name | Trader | % Success | |
|---|---|---|---|
| Big Data Zhou | Zhou Academy | 82.00 % | Subscribe |
| Option Superstars | James Catzen | 72.00 % | Subscribe |
| Tracking ONLY-VOLBAND DAILY BREAK- | Jay | 53.00 % | Follow |
| Mojo Day Trading | ProTrader Mike | 46.00 % | Subscribe |
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
We are not a registered investment advisor. All investments involve risk, individual's trading does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. References to specific securities should not be construed as a recommendation to buy or sell that security only mentioned for informational purposes.